Objectives: Gynecologic oncologists have recently begun using laparoscopic techniques to treat early stage cervical cancer. We evaluated a single institution's experience of laparoscopic radical hysterectomy and staging compared with laparotomy. 
INTRODUCTION
In the early 1900s, radical hysterectomy with pelvic lymphadenectomy was developed for the treatment of cervical cancer. 1 Initially, this was associated with high morbidity and mortality, so radiation became the favored treatment modality. However, with the advent of antibiotics, blood transfusions, and improvements in anesthesia, surgery regained popularity for the treatment of early stage cervical cancer (stage IA2 and IB1). The National Comprehensive Cancer Network (NCCN), 2 which publishes and continually updates practice guidelines for all areas of cancer care and is used in 115 countries around the world, currently recommends radical hysterectomy with pelvic lymphadenectomy for stage IA2 and IB1 disease in those patients who no longer desire fertility and are good surgical candidates. However, the guidelines do not specify the approach in which this procedure must be accomplished. Until the early 1990s, the standard surgical practice for early stage, nonbulky disease was radical abdominal hysterectomy with pelvic lymphadenectomy. In the 1990s, gynecologic oncologists began using a laparoscopic approach with the aim of completing the same surgery with less morbidity. 3 Since that time, several studies have looked at the feasibility of completing the surgery laparoscopically. More recently, researchers have examined the morbidity and mortality rates associated with the newer technique. 4 -23 In this study, we compare a cohort of women who underwent laparoscopic radical hysterectomy for early stage cervical cancer to a matched group that underwent open radical hysterectomy and assess the surgical outcomes for both groups.
MATERIALS AND METHODS
After obtaining institutional review board approval, a retrospective chart review was performed looking for all women who had undergone a laparoscopic-assisted vaginal radical hysterectomy and pelvic lymph node dissection for early stage cervical cancer at Magee-Womens Hospital of the University of Pittsburgh. Between July 2003 and April 2009, nine patients with stage IA2 and IB1 cervical cancer who had undergone the above procedure were identified. The initial diagnosis of cervical cancer was made by histologically confirmed biopsy prior to surgical resection. The patient's assigned stage was based on the clinical staging set forth by the International Federation of Gynecology and Obstetrics (FIGO). 24 We matched a 2:1 cohort of patients by stage who underwent a radical hysterectomy and lymph node dissection through laparotomy. We chose the case immediately proceeding and following each laparoscopic case for comparison. The choice to perform the procedure laparoscopically was left to the discretion of the surgeon after a thorough discussion of risks and benefits with the patients.
Data were then collected on both the laparoscopic cases and the matched open cases. These data included patient demographics of age, body mass index (BMI), race, and tobacco use, tumor histological characteristics, presence of positive surgical margins, number of lymph nodes, and the presence of positive lymph nodes. Additionally, we collected operative outcomes including operating time, blood loss, transfusion requirement, and operative complications, as well as postoperative follow-up including postoperative wound infections, length of stay, adjuvant treatment, and recurrence.
None of the parameters analyzed during this study were used to include or exclude patients from the study. All data points were used for comparison between the 2 techniques to determine the feasibility of the laparoscopic technique as an alternative method to laparotomy. Statistical analysis was performed using the chi-square test or t test where appropriate, with a significance level of PϽ0.05.
RESULTS
A total of 9 patients were found to have undergone laparoscopic radical hysterectomy, with 18 matched open controls. The average age was 41. 4 Table 2 ). There were no noted recurrences of disease in either group. Until laparoscopic radical hysterectomy is more widely practiced, the feasibility and applicability will have to be assessed through retrospective studies.
This study adds to the already published data that support the use of laparoscopy as an alternative to laparotomy.
Although it has a limited number of patients, this study does compare outcomes to a similarly matched control group of the same time period adding to the small pool of growing data that show equivalent outcomes for this new procedure. Even though the difference in length of hospital stay was the only measurement that proved to be statistically significant, postoperative wound infection, blood loss, and operative complications all appear to be lower in the laparoscopic cases than in the laparotomy cases, and may be statistically significantly different in a larger series. Additionally, shorter length of stay after laparoscopy has been reported previously and is again confirmed by our findings. 7,8,13,14,16 -19,22 We found that mean operating time was not significantly different between these 2 procedures, 231. 18, 19, 22 This is likely because laparoscopy is a newer technique, and a learning curve is expected for new procedures. As surgeons become more comfortable with the technique, operating time should be reduced. Of note, there were some operating times that were longer than would be expected in both the open and the laparoscopic groups. The laparotomy case that took 340 minutes was an outlier with the rest of the cases well under 300 minutes. This case was complicated by a left external iliac artery injury and required a longer operating time for repair. Early experience with this technique may also explain the great variance in operating time documented within the laparoscopic cases. There were no noted complications in the laparoscopic case that took 313 minutes; however, it was only the second case in the series. Comparing this to the last case recorded in this series, which was completed in 148 minutes, without complications, it is easy to surmise that over time and with practice this procedure became easier and therefore the surgery was completed more quickly. As the laparoscopic surgical approach is accepted as equivalent in cancer outcomes, it is expected that more surgeons will adopt the technique, because of decreased morbidity and faster recovery for their patients.
Some may speculate that the cases done through laparoscopy may have been chosen because of certain patient characteristics, like lower BMI, no previous surgeries, and fewer medical comorbidities, which may make the cases easier and therefore result in fewer operative and postoperative complications. However, looking through these 2 patient populations, the average BMI for the individuals in both groups were similar, as well as the range of BMIs, 20.6 to 36.1 in the laparoscopic group and 17 to 38.3 in the laparotomy group. Similarly, both groups were heterogenous in regard to their past surgical histories and their medical comorbidities, noting that none of the patients were taking immunosuppressants, and the 2 with diabetes mellitus did not have postoperative wound infections. There was a mixture of smokers and nonsmokers. On an interesting note, all of the patients who had wound infections in the laparotomy group were smokers, except one that was a former smoker. It should be noted that even though there were smokers in the laparoscopic group, there were no wound infections in this group. Some may argue that there was limited follow-up, and so there was not enough time to detect all of the wound infections. However, the shortest follow-up period was 13 months, so it is unlikely that any wound infections directly associated with the surgery would be missed within this time period.
As noted by other groups, the blood loss with laparoscopic surgery tends to be less than with traditional laparotomy. This is one of the biggest reasons why surgeons started moving toward laparoscopic surgery in the beginning and this continues to hold true. In our small set of patients, it did not reach statistical significance; however, the trend is similar to what has been reported before and adds credence to the overall argument for the use of laparoscopy as an alternative to laparotomy. 7, 9, 10, 16, 17, 19, 22 Additionally, there were no operative complications in the laparoscopic group, which also supports previous findings that laparoscopy is a safe alternative. 10,13,16 -23 Long-term cancer outcome data are not available in our series due to small numbers and short follow-up. However, no patient had a recurrence in either the laparoscopic group over a median follow-up of 35.3 months (range, 13 to 82) or in the laparotomy group over a median follow-up of 35.1 months (range, 13 to 78).
There are limitations to this study, including the retrospective nature of the work, the small sample size, and the short follow-up for the more recent cases. With regard to the retrospective design, as mentioned before, there have not been any large prospective trials to date, because this is a relatively new surgical technique that is being applied to a standardized guideline of care. Because this is a new approach, it is not being widely practiced among the gynecologic oncologists at Magee-Womens Hospital. Therefore, to assess the current experience and gather enough cases to establish a pattern of outcomes, it was necessary to turn to historical data. The retrospective nature lends itself to criticism in that there is no great uniformity to the patient population or a standardized follow-up plan. However, because there were no strict standardizations as with a designed prospective trial, the outcomes may be more generalizable. This is because there will be inevitable practice variances among different gynecologic oncologists as well as patients who return for continued care. There are documented care records for this series of patients, without any loss to follow-up, which gives the results credence, even though the more recent cases have a limited time to assess recurrence and survival.
The second notable limitation is the sample size, which speaks to the newness of this technique. As mentioned above, this technique first became a part of gynecologic oncology in the early 1990s, gaining popularity over the last 20 years. However, as with any new procedure, it takes time and training to adopt a method as a regular part of surgical practice. For this reason, the cases presented within this series are limited in number. However, as mentioned before, the trends noted within this study follow what has been seen in the literature to date. There are no published data on exactly how many radical hysterectomies are done laparoscopically in the United States every year and no central reporting or large trials looking at laparoscopic radical hysterectomy. Until we have data like this, it is important to continue to report on institutional experiences to add to the growing data on the feasibility and safety of the technique as an alternative to standard laparotomy.
Lastly, the follow-up in this series was over a long range of time, starting with cases in 2003 and ending in 2009. The early cases allow for adequate assessment of 5-year follow-up with regard to recurrence and survival. However, the data are clearly limited with respect to the more recent cases. We report that we did not have any cases of recurrence or death, which does not align with all the current outcome literature. 12-15,18 -22 This is likely secondary to the short interval follow-up from the later cases as well as the limited number in the series. Even with these limitations, it shows promise that these patients have similar outcomes, if not improved, when compared to the open cases.
CONCLUSION
Our results add to the results of a growing number of surgeons and researchers who have shown that laparoscopy is a feasible alternative to laparotomy for radical hysterectomy. This minimally invasive procedure should be considered for the treatment of any women with small volume invasive cervical cancer.
